PANews reported on May 16 that Basel Medical Group announced that it has initiated exclusive negotiations with several institutional investors on a $1 billion BTC acquisition plan, and plans to achieve financial restructuring through innovative share swaps. The transaction will significantly enhance its balance sheet, providing financial flexibility, risk resistance and M&A support for its expansion in Asia's high-growth medical market. The CEO said that this move will enhance the company's capital base as a leading regional medical group, and the transaction is expected to be completed within this quarter.